- Retraction Note
- Open access
- Published:
Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 16 (2023)
The Original Article was published on 29 August 2018
Retraction Note: J Exp Clin Cancer Res 37, 202 (2018)
https://doi.org/10.1186/s13046-018-0875-3
The Editor-in-Chief has retracted this article because data presented in Figs. 2, 3 and 4 were duplicated from previously published articles. Specifically, a set of staining images in Fig. 2I had previously been published as Fig. 3E in [1]. The actin blot in Fig. 3D had been published as part of Fig. 4B in [2], and as part of 7H in [3]. The BT474 blot in Fig. 4C was previously published as P2 in Fig. 2F of [4]. The SKBR-3 MyD88 blot in Fig. 4D originally appeared as snail in Fig. 5D in [5]. The Editor-in-Chief no longer has confidence in the results and conclusions of this article. Huaying Dong states that all authors agree to this retraction.
References
Liu H, et al. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget. 2017;8(60):101899–910. Web. 28 Nov. 2022. https://doi.org/10.18632/oncotarget.22058.
Dong H, Wang W, Mo S, et al. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation. J Cell Mol Med. 2018;22:4935–47. https://doi.org/10.1111/jcmm.13758.
Kang M, Ren M, Li Y, et al. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA. J Exp Clin Cancer Res. 2018;37:171. https://doi.org/10.1186/s13046-018-0845-9.
Zhang W, Cai X, Yu J, Lu X, Qian Q, Qian W. Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer Retraction in /10.3892/ijo.2022.5458. Int J Oncol. 2018;53(2):527–38.
Ji Q, Liu X, Han Z, et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 2015;15:97. https://doi.org/10.1186/s12885-015-1119-y.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Dong, H., Wang, W., Mo, S. et al. Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. J Exp Clin Cancer Res 42, 16 (2023). https://doi.org/10.1186/s13046-023-02596-2
Published:
DOI: https://doi.org/10.1186/s13046-023-02596-2